Medicalsystem Biotechnology Co., Ltd. (300439.SZ)
CNY 11.16
(-0.36%)
CNY 11.16
(-0.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.88 Billion | 2.48 Billion | 2.25 Billion | 2.3 Billion | 3.13 Billion | 3.13 Billion |
| Cost of Revenue | 1.05 Billion | 1.53 Billion | 1.34 Billion | 1.45 Billion | 2.05 Billion | 2.03 Billion |
| Gross Profit | 834.37 Million | 949.61 Million | 911.3 Million | 848.29 Million | 1.07 Billion | 1.09 Billion |
| Operating Expenses | 562.06 Million | 636.78 Million | 615.39 Million | 579.73 Million | 700.54 Million | 640.72 Million |
| Selling, General and Administrative Expenses | 374.73 Million | 364.71 Million | 351.65 Million | 335.85 Million | 441.29 Million | 391.49 Million |
| Research and Development Expenses | 137.94 Million | 171.78 Million | 150.68 Million | 135.48 Million | 128.26 Million | 109.64 Million |
| Other Expenses | - | 100.28 Million | 113.05 Million | 108.39 Million | 130.98 Million | -1.3 Million |
| Cost and Expenses | 1.6 Billion | 2.17 Billion | 1.95 Billion | 2.03 Billion | 2.75 Billion | 2.68 Billion |
| Operating Income | 279.11 Million | 322.01 Million | 294.19 Million | 461.42 Million | 410.71 Million | 341.71 Million |
| Interest Expense | 10.91 Million | 15.63 Million | 29.26 Million | 55.13 Million | 81.4 Million | 84.17 Million |
| Income Tax Expense | 36.17 Million | 18.1 Million | 28.08 Million | 53.48 Million | 51.55 Million | 91.72 Million |
| Earnings before Tax | 279.36 Million | 223.3 Million | 218.23 Million | 347.04 Million | -525.07 Million | 340.4 Million |
| Net Income | 256.55 Million | 198.52 Million | 179.48 Million | 299.48 Million | -576.62 Million | 241.17 Million |
| Earnings Per Share Basic | 0.67 | 0.52 | 0.48 | 0.87 | -1.68 | 0.71 |
| Earnings Per Share Diluted | 0.67 | 0.52 | 0.48 | 0.87 | -1.68 | 0.70 |
| Weighted Average Shares Outstanding | 382.91 Million | 382.99 Million | 373.93 Million | 344.23 Million | 343.5 Million | 339.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 382.91 Million | 382.99 Million | 373.93 Million | 344.23 Million | 343.5 Million | 344.53 Million |
| Gross Margin | 0.44 | 0.38 | 0.40 | 0.37 | 0.34 | 0.35 |
| EBIT Margin | 0.25 | 0.21 | 0.22 | 0.28 | 0.18 | 0.20 |
| Profit Margin | 0.14 | 0.08 | 0.08 | 0.13 | -0.18 | 0.08 |
| EBITDA | 475.01 Million | 430.61 Million | 442.32 Million | 590.22 Million | 572.19 Million | 574.9 Million |
| Earnings Before Tax Margin | 0.15 | 0.13 | 0.13 | 0.20 | 0.13 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 457.58 Million | 467.61 Million | 481.51 Million | 1.86 Billion | 411.97 Million | 493.82 Million |
| Cost of Revenue | 254.51 Million | 229.93 Million | 278 Million | 1.09 Billion | 248.19 Million | 268.12 Million |
| Gross Profit | 203.07 Million | 237.68 Million | 203.5 Million | 766.93 Million | 163.77 Million | 225.69 Million |
| Operating Expenses | 150.5 Million | 137.95 Million | 130.2 Million | 514.18 Million | 150.06 Million | 166.97 Million |
| Selling, General and Administrative Expenses | 238.67 Million | 43.31 Million | 94.58 Million | - | 101.24 Million | 179.74 Million |
| Research and Development Expenses | 38.38 Million | 38.07 Million | 38.29 Million | - | 28.12 Million | 40.62 Million |
| Other Expenses | -126.55 Million | 6.4 Million | 1.14 Million | -1.5 Million | -20.7 Million | 4.31 Million |
| Cost and Expenses | 405.01 Million | 367.89 Million | 408.21 Million | 1.61 Billion | 398.26 Million | 435.09 Million |
| Operating Income | 63.04 Million | 102.07 Million | 85.09 Million | 252.75 Million | 13.7 Million | 66.96 Million |
| Interest Expense | 237.37 Thousand | 938.66 Thousand | 338.36 Thousand | 10.66 Million | 6.41 Million | 624.44 Thousand |
| Income Tax Expense | 15.26 Million | 8.19 Million | 8.18 Million | 36.17 Million | -3.88 Million | 17.37 Million |
| Earnings before Tax | 60.27 Million | 108.47 Million | 86.23 Million | 279.36 Million | 28.77 Million | 71.28 Million |
| Net Income | 45.9 Million | 99.36 Million | 79.09 Million | 256.55 Million | 26.59 Million | 55.09 Million |
| Earnings Per Share Basic | 0.12 | 0.26 | 0.21 | - | 0.07 | 0.14 |
| Earnings Per Share Diluted | 0.12 | 0.26 | 0.21 | - | 0.07 | 0.14 |
| Weighted Average Shares Outstanding | 382.99 Million | 382.99 Million | 376.65 Million | 382.99 Million | 382.99 Million | 382.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 382.99 Million | 382.99 Million | 376.65 Million | 382.99 Million | 382.99 Million | 382.99 Million |
| Gross Margin | 0.44 | 0.51 | 0.42 | 0.41 | 0.40 | 0.46 |
| EBIT Margin | 0.13 | 0.25 | 0.16 | - | 0.14 | 0.14 |
| Profit Margin | 0.10 | 0.21 | 0.16 | 0.14 | 0.06 | 0.11 |
| EBITDA | 60.5 Million | 116.29 Million | 78.98 Million | - | 56.72 Million | 71.36 Million |
| Earnings Before Tax Margin | 0.14 | 0.22 | 0.18 | 0.14 | 0.03 | 0.14 |
LUV
SYUP
IQAIF
VITFF
600148
CTM